Welcome to the Phacilitate Oncology Leaders' Forum 2007
Defining the oncology therapeutics marketplace of 2017 - what are the key strategic decisions that your organization must make today to meet the future demands of regulator, payer, physician and patient?
Driving efficiency in oncology clinical development through the application of innovative clinical trial designs and biomarkers
Delivering a blueprint for the successful oncology R&D portfolio of the future - what will be the next major technology areas to establish themselves in the marketplace?